BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ. 2009;338:a2752. [PMID: 19129307 DOI: 10.1136/bmj.a2752] [Cited by in Crossref: 106] [Cited by in F6Publishing: 83] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Baena MI, Fajardo PC, Pintor-mármol A, Faus MJ, Marín R, Zarzuelo A, Martínez-olmos J, Martínez-martínez F. Negative clinical outcomes of medication resulting in emergency department visits. Eur J Clin Pharmacol 2014;70:79-87. [DOI: 10.1007/s00228-013-1562-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
2 El Morabet N, Uitvlugt EB, van den Bemt BJ, van den Bemt PM, Janssen MJ, Karapinar-çarkit F. Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review. J Am Geriatr Soc 2018;66:602-8. [DOI: 10.1111/jgs.15244] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
3 Linkens AEMJH, Milosevic V, van der Kuy PHM, Damen-Hendriks VH, Mestres Gonzalvo C, Hurkens KPGM. Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm 2020;42:1243-51. [PMID: 32472324 DOI: 10.1007/s11096-020-01040-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Islam T, O'Connell B, Hawkins M. Factors associated with transfers from healthcare facilities among readmitted older adults with chronic illness. Aust Health Rev 2014;38:354-62. [PMID: 24670934 DOI: 10.1071/AH13133] [Reference Citation Analysis]
5 Lin YW, Zhou Y, Faghri F, Shaw MJ, Campbell RH. Analysis and prediction of unplanned intensive care unit readmission using recurrent neural networks with long short-term memory. PLoS One 2019;14:e0218942. [PMID: 31283759 DOI: 10.1371/journal.pone.0218942] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 9.3] [Reference Citation Analysis]
6 Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Bereznicki LR. Repeat Adverse Drug Reaction-Related Hospital Admissions in Elderly Australians: A Retrospective Study at the Royal Hobart Hospital. Drugs Aging 2017;34:777-83. [PMID: 28952130 DOI: 10.1007/s40266-017-0490-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
7 Morrison C, MacRae Y. Promoting Safer Use of High-Risk Pharmacotherapy: Impact of Pharmacist-Led Targeted Medication Reviews. Drugs Real World Outcomes 2015;2:261-71. [PMID: 27747572 DOI: 10.1007/s40801-015-0031-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lehnert T, Heider D, Leicht H, Heinrich S, Corrieri S, Luppa M, Riedel-heller S, König H. Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions. Med Care Res Rev 2011;68:387-420. [DOI: 10.1177/1077558711399580] [Cited by in Crossref: 372] [Cited by in F6Publishing: 334] [Article Influence: 33.8] [Reference Citation Analysis]
9 Candeias C, Gama J, Rodrigues M, Falcão A, Alves G. Potentially Inappropriate Medications and Potential Prescribing Omissions in Elderly Patients Receiving Post-Acute and Long-Term Care: Application of Screening Tool of Older People's Prescriptions/Screening Tool to Alert to Right Treatment Criteria. Front Pharmacol 2021;12:747523. [PMID: 34737705 DOI: 10.3389/fphar.2021.747523] [Reference Citation Analysis]
10 Hohl CM, Karpov A, Reddekopp L, Doyle-Waters M, Stausberg J. ICD-10 codes used to identify adverse drug events in administrative data: a systematic review. J Am Med Inform Assoc 2014;21:547-57. [PMID: 24222671 DOI: 10.1136/amiajnl-2013-002116] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
11 Fusco D, Lattanzio F, Tosato M, Corsonello A, Cherubini A, Volpato S, Maraldi C, Ruggiero C, Onder G. Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: rationale and methodology. Drugs Aging 2009;26 Suppl 1:3-13. [PMID: 20136165 DOI: 10.2165/11534620-000000000-00000] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
12 Putilina MV. [Comorbidity in elderly patients]. Zh Nevrol Psikhiatr Im S S Korsakova 2016;116:106-11. [PMID: 27437546 DOI: 10.17116/jnevro201611651106-111] [Cited by in Crossref: 10] [Article Influence: 1.7] [Reference Citation Analysis]
13 Eraslan S, Kizilgul M, Uzunlulu M, Colak Y, Ozturk O, Tuncer I. Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease. Minerva Med. 2013;104:447-453. [PMID: 24008607 DOI: 10.3399/bjgp13x670660] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
14 Shadmi E, Flaks-Manov N, Hoshen M, Goldman O, Bitterman H, Balicer RD. Predicting 30-day readmissions with preadmission electronic health record data. Med Care 2015;53:283-9. [PMID: 25634089 DOI: 10.1097/MLR.0000000000000315] [Cited by in Crossref: 70] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
15 Onder G, Landi F, Fusco D, Corsonello A, Tosato M, Battaglia M, Mastropaolo S, Settanni S, Antocicco M, Lattanzio F. Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging 2014;31:33-45. [PMID: 24234805 DOI: 10.1007/s40266-013-0134-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
16 Ben-Yehuda A, Bitton Y, Sharon P, Rotfeld E, Armon T, Muszkat M. Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: a cohort, case-control study. Drugs Aging 2011;28:491-500. [PMID: 21639408 DOI: 10.2165/11590610-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
17 Sikdar KC, Dowden J, Alaghehbandan R, Macdonald D, Wang PP, Gadag V. Adverse Drug Reactions in Elderly Hospitalized Patients: A 12-Year Population-Based Retrospective Cohort Study. Ann Pharmacother 2012;46:960-71. [DOI: 10.1345/aph.1q529] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
18 Corsonello A, Onder G, Bustacchini S, Provinciali M, Garasto S, Gareri P, Lattanzio F. Estimating renal function to reduce the risk of adverse drug reactions. Drug Saf 2012;35 Suppl 1:47-54. [PMID: 23446785 DOI: 10.1007/BF03319102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Lenssen R, Schmitz K, Griesel C, Heidenreich A, Schulz JB, Trautwein C, Marx N, Fitzner C, Jaehde U, Eisert A. Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial. BMC Geriatr 2018;18:135. [PMID: 29898670 DOI: 10.1186/s12877-018-0814-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
20 Ofori-Asenso R, Agyeman AA. Irrational Use of Medicines-A Summary of Key Concepts. Pharmacy (Basel) 2016;4:E35. [PMID: 28970408 DOI: 10.3390/pharmacy4040035] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
21 Angamo MT, Curtain CM, Chalmers L, Yilma D, Bereznicki L. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study. PLoS One 2017;12:e0186631. [PMID: 29036230 DOI: 10.1371/journal.pone.0186631] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
22 Coetzee R, Johnson Y, van Niekerk J, Namane M. Amitriptyline prescribing in public sector healthcare facilities in the Western Cape, South Africa. PLoS One 2020;15:e0231675. [PMID: 32311002 DOI: 10.1371/journal.pone.0231675] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Breuker C, Faucanié M, Laureau M, Perier D, Pinzani V, Marin G, Sebbane M, Villiet M. Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial. Trials 2021;22:521. [PMID: 34362410 DOI: 10.1186/s13063-021-05501-4] [Reference Citation Analysis]
24 Dumbreck S, Flynn A, Nairn M, Wilson M, Treweek S, Mercer SW, Alderson P, Thompson A, Payne K, Guthrie B. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 2015;350:h949. [PMID: 25762567 DOI: 10.1136/bmj.h949] [Cited by in Crossref: 146] [Cited by in F6Publishing: 109] [Article Influence: 20.9] [Reference Citation Analysis]
25 Dupouy J, Moulis G, Tubery M, Ecoiffier M, Sommet A, Poutrain JC, Arlet P, Lapeyre-Mestre M. Which adverse events are related to health care during hospitalization in elderly inpatients? Int J Med Sci 2013;10:1224-30. [PMID: 23935400 DOI: 10.7150/ijms.6640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Leendertse AJ, Visser D, Egberts AC, van den Bemt PM. The Relationship Between Study Characteristics and the Prevalence of Medication-Related Hospitalizations: A Literature Review and Novel Analysis. Drug Safety 2010;33:233-44. [DOI: 10.2165/11319030-000000000-00000] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
27 Sloot S, Boland J, Snowden JA, Ezaydi Y, Foster A, Gethin A, Green T, Chopra L, Verhagen S, Vissers K, Engels Y, Ahmedzai SH. Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study. Support Care Cancer 2015;23:671-8. [PMID: 25160491 DOI: 10.1007/s00520-014-2358-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
28 Bassi PU, Osakwe AI, Ogar CK, Elagbaje C, Nwankwo BB, Balogun ST, Ntadom GN, Isah AO. Impact of comorbidity on adverse drug reaction profile in a cohort of patients treated with Artemisinin combination therapies for uncomplicated malaria in Nigeria. Pharmacol Res Perspect 2017;5:e00302. [PMID: 28357128 DOI: 10.1002/prp2.302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gallelli L, Colosimo M, Tolotta GA, Falcone D, Luberto L, Curto LS, Rende P, Mazzei F, Marigliano NM, De Sarro G, Cucchiara S. Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol 2010;66:137-44. [DOI: 10.1007/s00228-009-0751-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
30 Hauviller L, Eyvrard F, Garnault V, Rousseau V, Molinier L, Montastruc JL, Bagheri H. Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years. Eur J Clin Pharmacol 2016;72:631-9. [PMID: 26884320 DOI: 10.1007/s00228-016-2022-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
31 Onder G, van der Cammen TJ, Petrovic M, Somers A, Rajkumar C. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing 2013;42:284-91. [PMID: 23537588 DOI: 10.1093/ageing/aft038] [Cited by in Crossref: 82] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
32 Tangiisuran B, Scutt G, Stevenson J, Wright J, Onder G, Petrovic M, van der Cammen TJ, Rajkumar C, Davies G. Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton Adverse Drug Reactions Risk (BADRI) model. PLoS One 2014;9:e111254. [PMID: 25356898 DOI: 10.1371/journal.pone.0111254] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
33 Lea M, Mowe M, Mathiesen L, Kvernrød K, Skovlund E, Molden E. Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward. PLoS One 2019;14:e0220071. [PMID: 31329634 DOI: 10.1371/journal.pone.0220071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
34 Abizanda Soler P, Paterna Mellinas G, Martínez Sánchez E, López Jiménez E. [Comorbidity in the elderly: utility and validity of assessment tools]. Rev Esp Geriatr Gerontol 2010;45:219-28. [PMID: 20488585 DOI: 10.1016/j.regg.2009.10.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
35 Michel JL, Jackson TJ. Australian Hospital Data: Not Just for Funding. HIM J 2009;38:53-8. [DOI: 10.1177/183335830903800108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
36 St Peter WL, Wazny LD, Patel UD. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens 2013;22:656-62. [PMID: 24076556 DOI: 10.1097/MNH.0b013e328365b364] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
37 Jeffrey AW, Huang Y, de Boer WB, Adams LA, MacQuillan G, Speers D, Joseph J, Jeffrey GP. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World J Hepatol 2017; 9(19): 850-856 [PMID: 28740596 DOI: 10.4254/wjh.v9.i19.850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
38 Akazawa M, Imai H, Igarashi A, Tsutani K. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother 2010;8:146-60. [PMID: 20439064 DOI: 10.1016/j.amjopharm.2010.03.005] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 8.3] [Reference Citation Analysis]
39 Hartholt KA, van der Velde N, Looman CW, Panneman MJ, van Beeck EF, Patka P, van der Cammen TJ. Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugs. PLoS One 2010;5:e13977. [PMID: 21103046 DOI: 10.1371/journal.pone.0013977] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
40 Willson MN, Greer CL, Weeks DL. Medication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacother 2014;48:26-32. [PMID: 24259639 DOI: 10.1177/1060028013510898] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
41 Roque KE, Melo ECP. Tempo de internação e a ocorrência de eventos adversos a medicamentos: uma questão da enfermagem. Esc Anna Nery 2011;15:595-601. [DOI: 10.1590/s1414-81452011000300022] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
42 Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR. Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool. Clin Interv Aging 2016;11:497-505. [PMID: 27194906 DOI: 10.2147/CIA.S99097] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
43 Sura SD, Carnahan RM, Chen H, Aparasu RR. Prevalence and determinants of anticholinergic medication use in elderly dementia patients. Drugs Aging 2013;30:837-44. [PMID: 23881698 DOI: 10.1007/s40266-013-0104-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
44 Petty D. Deprescribing: When and how to stop a medicine. Nurse Prescribing 2015;13:358-61. [DOI: 10.12968/npre.2015.13.7.358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
45 Chayé H, Bernard M, Tubéry M, Rousseau V, Ecoiffier M, Montastruc J, Bagheri H. Réhospitalisations d’origine médicamenteuse : étude pilote dans un service de post-urgences médicales d’un hôpital universitaire français. La Revue de Médecine Interne 2015;36:450-6. [DOI: 10.1016/j.revmed.2014.11.016] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
46 Brunner-La Rocca HP, Fleischhacker L, Golubnitschaja O, Heemskerk F, Helms T, Hoedemakers T, Allianses SH, Jaarsma T, Kinkorova J, Ramaekers J, Ruff P, Schnur I, Vanoli E, Verdu J, Zippel-Schultz B. Challenges in personalised management of chronic diseases-heart failure as prominent example to advance the care process. EPMA J 2015;7:2. [PMID: 26913090 DOI: 10.1186/s13167-016-0051-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
47 Micaglio E, Locati ET, Monasky MM, Romani F, Heilbron F, Pappone C. Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine. Front Pharmacol 2021;12:651720. [PMID: 33995067 DOI: 10.3389/fphar.2021.651720] [Reference Citation Analysis]
48 Lee CY, George J, Elliott RA, Chapman CB, Stewart K. Exploring Medication Risk among Older Residents in Supported Residential Services: A Cross-Sectional Study. Journal of Pharmacy Practice and Research 2011;41:98-101. [DOI: 10.1002/j.2055-2335.2011.tb00673.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
49 Weeks DL, Willson MN, Greer CL. Differences in Complexity of Discharge Medication Regimens between Men and Women Discharged from Acute Care to Home following Total Joint Arthroplasty. Hosp Pharm 2012;47:197-205. [DOI: 10.1310/hpj4703-197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Bertsche T, Pfaff J, Schiller P, Kaltschmidt J, Pruszydlo MG, Stremmel W, Walter-Sack I, Haefeli WE, Encke J. Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. Intensive Care Med. 2010;36:665-672. [PMID: 20143221 DOI: 10.1007/s00134-010-1778-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
51 Rodrigues MC, Oliveira Cd. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem 2016;24:e2800. [PMID: 27598380 DOI: 10.1590/1518-8345.1316.2800] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
52 Lefèvre L, Jourdain M, Fournier JP. Processes and determinants of integration of eGFR in physicians' drug prescriptions: a qualitative study of semi-structured interviews. Prim Health Care Res Dev 2019;20:e143. [PMID: 31640822 DOI: 10.1017/S1463423619000847] [Reference Citation Analysis]
53 Yang J, Wang L, Phadke NA, Wickner PG, Mancini CM, Blumenthal KG, Zhou L. Development and Validation of a Deep Learning Model for Detection of Allergic Reactions Using Safety Event Reports Across Hospitals. JAMA Netw Open 2020;3:e2022836. [PMID: 33196805 DOI: 10.1001/jamanetworkopen.2020.22836] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
54 Kwok CS, Martinez SC, Pancholy S, Ahmed W, Al-Shaibi K, Potts J, Mohamed M, Kontopantelis E, Curzen N, Mamas MA. Effect of Comorbidity On Unplanned Readmissions After Percutaneous Coronary Intervention (From The Nationwide Readmission Database). Sci Rep 2018;8:11156. [PMID: 30042466 DOI: 10.1038/s41598-018-29303-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
55 Boland MR, Jacunski A, Lorberbaum T, Romano JD, Moskovitch R, Tatonetti NP. Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms. Wiley Interdiscip Rev Syst Biol Med 2016;8:104-22. [PMID: 26559926 DOI: 10.1002/wsbm.1323] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
56 Liao PJ, Mao CT, Chen TL, Deng ST, Hsu KH. Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case-control study. BMJ Open 2019;9:e026771. [PMID: 31079084 DOI: 10.1136/bmjopen-2018-026771] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
57 Sumida CA, Vo TT, Van Etten EJ, Schmitter-Edgecombe M. Medication Management Performance and Associated Cognitive Correlates in Healthy Older Adults and Older Adults with aMCI. Arch Clin Neuropsychol 2019;34:290-300. [PMID: 29912269 DOI: 10.1093/arclin/acy038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
58 Myrka A, Butterfield S, B. GJ, Amin P, Ambrosy S, Woellmer C, Glock S. A Systems-Based Medication Reconciliation Process: With Implications for Home Healthcare. Home Healthcare Nurse 2011;29:624-35. [DOI: 10.1097/nhh.0b013e31823454e5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
59 Elliott RA, C. Booth J. Problems with medicine use in older Australians: a review of recent literature: Problems with medicine use in older Australians. J Pharm Pract Res 2014;44:258-71. [DOI: 10.1002/jppr.1041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
60 Flynn A, Anderson C. Meaningful collaboration. Nursing Management 2012;43:2-5. [DOI: 10.1097/01.numa.0000423782.68785.ea] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
61 Margolis SA, Zughaft Sears M, Daiello LA, Solon C, Nakhutina L, Hoogendoorn CJ, Gonzalez JS. Anticholinergic/sedative drug burden predicts worse memory acquisition in older racially/ethnically diverse patients with type 2 diabetes mellitus. Int J Geriatr Psychiatry 2019;34:1545-54. [DOI: 10.1002/gps.5173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM, Pugh MJ. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc 2012;60:34-41. [PMID: 22150441 DOI: 10.1111/j.1532-5415.2011.03772.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 121] [Article Influence: 12.4] [Reference Citation Analysis]
63 de Jong MR, Van der Elst M, Hartholt KA. Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies. Ther Adv Drug Saf 2013;4:147-54. [PMID: 25114778 DOI: 10.1177/2042098613486829] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
64 Cruz-Jentoft AJ, Franco A, Sommer P, Baeyens JP, Jankowska E, Maggi A, Ponikowski P, Rys A, Szczerbinska K, Michel JP, Milewicz A. Silver paper: the future of health promotion and preventive actions, basic research, and clinical aspects of age-related disease--a report of the European Summit on Age-Related Disease. Aging Clin Exp Res 2009;21:376-85. [PMID: 20154507 DOI: 10.1007/BF03327452] [Cited by in Crossref: 39] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
65 Haanpää ML, Gourlay GK, Kent JL, Miaskowski C, Raja SN, Schmader KE, Wells CD. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc 2010;85:S15-25. [PMID: 20194144 DOI: 10.4065/mcp.2009.0645] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
66 Long S, Vincent C. Patient Safety. In: Sinclair AJ, Morley JE, Vellas B, editors. Pathy's Principles and Practice of Geriatric Medicine. Chichester: John Wiley & Sons, Ltd; 2012. pp. 153-70. [DOI: 10.1002/9781119952930.ch14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Yu YM, Lee JY, Lee E. Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients. Maturitas 2017;103:54-9. [PMID: 28778333 DOI: 10.1016/j.maturitas.2017.06.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
68 Pereira F, Verloo H, Zhivko T, Di Giovanni S, Meyer-Massetti C, von Gunten A, Martins MM, Wernli B. Risk of 30-day hospital readmission associated with medical conditions and drug regimens of polymedicated, older inpatients discharged home: a registry-based cohort study. BMJ Open 2021;11:e052755. [PMID: 34261693 DOI: 10.1136/bmjopen-2021-052755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Regan AK, Klerk Nd, Moore HC, Omer SB, Shellam G, Effler PV. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: A retrospective cohort study. Vaccine 2016;34:3649-56. [PMID: 27216758 DOI: 10.1016/j.vaccine.2016.05.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
70 Scott I, Jayathissa S. Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J 2010;40:7-18. [PMID: 19712203 DOI: 10.1111/j.1445-5994.2009.02040.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
71 Monteiro Mantovani V, Moorhead S, de Abreu Almeida M, Rabelo-Silva ER. Adverse Reactions to Medications: Concept Analysis and Development of a New Risk Nursing Diagnosis. Int J Nurs Knowl 2020;31:87-93. [PMID: 30900386 DOI: 10.1111/2047-3095.12237] [Reference Citation Analysis]
72 Chinnaratha MA, Jeffrey GP, Macquillan G, Rossi E, de Boer BW, Speers DJ, Adams LA. Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models. Liver Int 2014;34:720-7. [DOI: 10.1111/liv.12306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
73 Blumenthal KG, Wolfson AR, Li Y, Seguin CM, Phadke NA, Banerji A, Mort E. Allergic Reactions Captured by Voluntary Reporting. J Patient Saf 2019. [PMID: 30720546 DOI: 10.1097/PTS.0000000000000568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
74 Juneja M, Euliano R, Satoskar R, Lewis JH. Polypharmacy and comorbidity are associated with a lower early virologic response in hepatitis C patients treated with first generation protease inhibitor triple therapy: a preliminary analysis. Dig Dis Sci 2013;58:3348-58. [PMID: 23925819 DOI: 10.1007/s10620-013-2812-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
75 Mota DM, Vigo Á, Kuchenbecker RS. [Recommendation of ICD-10 codes for surveillance of adverse drug reactions and drug intoxication]. Cien Saude Colet 2018;23:3041-54. [PMID: 30281741 DOI: 10.1590/1413-81232018239.20692016] [Reference Citation Analysis]
76 Parihar HS, Yin H, Gooch JL, Allen S, John S, Xuan J. Trends in hospital admissions due to antidepressant-related adverse drug events from 2001 to 2011 in the U.S. BMC Health Serv Res 2017;17:51. [PMID: 28103930 DOI: 10.1186/s12913-017-1993-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
77 Akindele MO, Useh U. Multimorbidity of chronic diseases of lifestyle among South African adults. Pan Afr Med J 2021;38:332. [PMID: 34285755 DOI: 10.11604/pamj.2021.38.332.15109] [Reference Citation Analysis]
78 Alfonso Silguero SA, Martínez-Reig M, Gómez Arnedo L, Juncos Martínez G, Romero Rizos L, Abizanda Soler P. [Chronic disease, mortality and disability in an elderly Spanish population: the FRADEA study]. Rev Esp Geriatr Gerontol 2014;49:51-8. [PMID: 24055095 DOI: 10.1016/j.regg.2013.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
79 Roque KE, Melo ECP. Avaliação dos eventos adversos a medicamentos no contexto hospitalar. Esc Anna Nery 2012;16:121-7. [DOI: 10.1590/s1414-81452012000100016] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
80 Gabe ME, Davies GA, Murphy F, Davies M, Johnstone L, Jordan S. Adverse drug reactions: treatment burdens and nurse-led medication monitoring: Adverse drug reactions and medication monitoring. Journal of Nursing Management 2011;19:377-92. [DOI: 10.1111/j.1365-2834.2011.01204.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
81 Kosilov KV, Alexandrovich LS, Gennadyevna KI, Viktorovna SO, Sergeevna ZN, Ivanovich AI. Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms. Int Neurourol J 2016;20:240-9. [PMID: 27706009 DOI: 10.5213/inj.1632520.260] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Mclachlan CYL, Yi M, Ling A, Jardine DL. Adverse drug events are a major cause of acute medical admission: ADE are a major cause of admission. Intern Med J 2014;44:633-8. [DOI: 10.1111/imj.12455] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
83 Roque KE, Tonini T, Melo EC. Adverse events in the intensive care unit: impact on mortality and length of stay in a prospective study. Cad Saude Publica 2016;32:e00081815. [PMID: 27783755 DOI: 10.1590/0102-311X00081815] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
84 Carey IM, Shah SM, Harris T, DeWilde S, Cook DG. A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index. J Clin Epidemiol 2013;66:436-44. [PMID: 23395517 DOI: 10.1016/j.jclinepi.2012.10.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
85 Casalini F, Salvetti S, Memmini S, Lucaccini E, Massimetti G, Lopalco PL, Privitera GP. Unplanned readmissions within 30 days after discharge: improving quality through easy prediction. International Journal for Quality in Health Care 2017;29:256-61. [DOI: 10.1093/intqhc/mzx011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
86 Salvi F, Marchetti A, D'Angelo F, Boemi M, Lattanzio F, Cherubini A. Adverse drug events as a cause of hospitalization in older adults. Drug Saf 2012;35 Suppl 1:29-45. [PMID: 23446784 DOI: 10.1007/BF03319101] [Cited by in Crossref: 84] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
87 Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med 2011;125:803-15. [PMID: 21120513 DOI: 10.1007/s00414-010-0536-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
88 Lee CY, George J, Elliott RA, Stewart K. Prevalence of medication-related risk factors among retirement village residents: a cross-sectional survey. Age Ageing 2010;39:581-7. [PMID: 20621929 DOI: 10.1093/ageing/afq079] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
89 Magdelijns FJ, Pijpers E, Rouhl RP, Hannemann PF, ten Broeke RH, Dings JT, Stehouwer CD, Stassen PM. Acute Hospital Admissions Because of Health Care-Related Adverse Events: A Retrospective Study of 5 Specialist Departments. J Am Med Dir Assoc 2015;16:1055-61. [PMID: 26255710 DOI: 10.1016/j.jamda.2015.06.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
90 O’mahony D, O’connor MN, Eustace J, Byrne S, Petrovic M, Gallagher P. The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients. Eur Geriatr Med 2018;9:191-9. [DOI: 10.1007/s41999-018-0030-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
91 Cheong V, Sowter J, Scally A, Hamilton N, Ali A, Silcock J. Medication-related risk factors and its association with repeated hospital admissions in frail elderly: A case control study. Research in Social and Administrative Pharmacy 2020;16:1318-22. [DOI: 10.1016/j.sapharm.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]